FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 080105003 | 72934-7426 | 72934-7426-6 | Salicylic Acid; Ciclopirox Olamine; Clobetasol Propionate | 3 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2024-2 | valid | 2026-10-21 | |
| SKNV | 72934-7426 | 72934-7426-6 | Haxchlodrex | 351037 CICLOPIROX 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3% | 3 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-7426 | 72934-7426-6 | Salicylic Acid; Ciclopirox Olamine; Clobetasol Propionate | 3 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2024-1 | valid | 2026-10-21 | |
| SKNV | 080105003 | 72934-7426 | 72934-7426-6 | Salicylic Acid; Ciclopirox Olamine; Clobetasol Propionate | 3 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2023-2 | valid | 2026-10-21 |